Loading organizations...
Perelel specializes in developing and distributing doctor-formulated nutritional supplements, specifically targeting women’s health needs across various life stages. The company crafts daily vitamin packs using clinically-backed ingredients delivered in highly bioavailable forms, spanning categories such as fertility, all trimesters of pregnancy, postpartum recovery, and perimenopause. Their approach centers on providing precise nutrient support tailored to the unique physiological demands of each distinct phase of a woman’s reproductive journey.
The company was founded in 2018 by Victoria Thain Gioia and Alex Taylor. The co-founders conceived Perelel out of a shared personal experience while both were pregnant, discovering a significant unmet need for high-quality, comprehensively formulated prenatal vitamins that truly addressed their evolving nutritional requirements and frustrations with existing market offerings. Their professional backgrounds contributed to their ability to identify and address this gap.
Perelel primarily serves women seeking optimized nutritional support from conception through perimenopause, emphasizing comprehensive wellness throughout their lives. The company’s vision is to empower women by providing science-backed, stage-specific vitamins and supplements, ensuring they receive essential nutrients precisely when their bodies need them most, thereby supporting overall health and well-being at every significant transition.
Perelel has raised $58.0M across 4 funding rounds.
Perelel has raised $58.0M in total across 4 funding rounds.
Perelel has raised $58.0M across 4 funding rounds. Most recently, it raised $20.0M Series B in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 29, 2026 | $20M Series B | — | — | Announced |
| Nov 20, 2025 | $27M Venture Round | Alicia Sontag | Selva Ventures, Unilever Ventures, Willow Growth | Announced |
| Jan 1, 2024 | $6M Series A | Madeline Kaplan, Rachel Harris, Amanda Schutzbank | Verity Venture Partners, Willow Growth Partners LP | Announced |
| Jul 1, 2022 | $5M Seed | Rachel Harris | M13, Bill Ackman, Aimee Song, ALI Weiss, Courtney Reum, Gaby Dalkin, Joan Nguyen, Julia Hunter, Marissa Hermer, Raissa Gerona, Rocky Barnes, Whitney Port, Willow Growth | Announced |
Perelel has raised $58.0M in total across 4 funding rounds.
Perelel's investors include Alicia Sontag, Selva Ventures, Unilever Ventures, Willow Growth, Madeline Kaplan, Rachel Harris, Amanda Schutzbank, Verity Venture Partners, Willow Growth Partners LP, M13, Bill Ackman, Aimee Song.
The premise of your query is incorrect: Perelel is not a technology company—it is a women's health supplement company.[1][2][3]
Perelel is a doctor-founded, research-backed supplement company that provides targeted vitamins and nutritional products for women across different stages of their hormonal lifecycle.[3] The company serves women navigating fertility, pregnancy, postpartum recovery, perimenopause, and menstrual cycle health by offering clinically-formulated vitamin packs designed with bioavailable ingredients tested for purity and safety.[2]
The core problem Perelel solves is the fragmentation and lack of scientific rigor in women's vitamins. As co-founder Alex Taylor noted, "The women's health category is at a breaking point with influencer-led brands and unproven product claims."[3] Perelel differentiates itself by grounding its products in clinical expertise and robust research rather than marketing hype.
The company has demonstrated strong growth momentum: it achieved profitability within five years of founding, doubled revenue year-over-year, and maintains category-leading subscriber retention rates.[3] In November 2025, Perelel secured a $27 million growth investment from Prelude Growth Partners, marking its evolution from a prenatal-focused brand to a comprehensive women's health company.[3]
Perelel was founded in 2020 by Victoria Thain Gioia, Alex Taylor, and Dr. Banafsheh Bayati, an OB/GYN who serves as the company's medical co-founder.[3][5] The idea emerged from personal frustration: Victoria was sourcing vitamins from multiple sources and sorting through pills and bottles each morning—an inefficient, expensive, and unsustainable approach.[5] When Victoria and Alex compared notes with other women, they realized the vitamin industry was fundamentally broken: it was underregulated, lacked transparent ingredient information, and offered oversimplified products that didn't account for women's changing hormonal needs.[5]
With Dr. Bayati's medical expertise, the founders set out to create stage-specific vitamin routines using bioavailable, research-backed ingredients in clinically-tested doses, delivered in simple daily packs.[5] The company is based in Los Angeles, California.[2]
Perelel operates within a rapidly consolidating women's health ecosystem. The company recently acquired Loom, a women's sexual health education platform, in October 2024, signaling expansion beyond supplements into holistic women's wellness.[2] This mirrors broader consolidation trends in sexual wellness startups, where companies like Dame and Hello Cake are acquiring complementary brands to build comprehensive platforms.
The timing is significant: women's health has become a venture-backed category as investors recognize underserved markets and the credibility gap in women's nutrition. Perelel's success—achieving profitability and attracting institutional growth capital—validates that science-backed, clinically-rigorous approaches resonate with consumers fatigued by unsubstantiated wellness claims.
Perelel is positioned to become a category leader in clinical women's health nutrition by leveraging its doctor-founded credibility in an increasingly crowded market. The $27 million growth round signals investor confidence in scaling beyond prenatal vitamins into a full-lifecycle women's health brand.
The company's next chapter likely involves deepening its product portfolio (evidenced by the Loom acquisition), expanding international operations, and potentially building a broader wellness ecosystem that combines supplements, education, and telehealth services. As consumer skepticism toward unproven wellness claims grows, Perelel's commitment to clinical rigor and transparency will likely become a competitive moat—transforming it from a niche prenatal brand into a trusted partner for women's health across all life stages.
